Resultados de búsqueda - Bernardo Stefanini
- Mostrando 1 - 7 Resultados de 7
-
1
Osteosarcopenia in NAFLD/MAFLD: An Underappreciated Clinical Problem in Chronic Liver Disease por Alessandra Musio, Federica Perazza, Laura Leoni, Bernardo Stefanini, Elton Dajti, Renata Menozzi, Maria Letizia Petroni, Antonio Colecchia, Federico Ravaioli
Publicado 2023Revisão -
2
Liver decompensation in patients with hepatocellular carcinoma treated with Atezolizumab plus Bevacizumab: a real-life study por Leonardo Stella, Maria Pallozzi, Lucia Cerrito, Francesco Santopaolo, Francesco Tovoli, Clémence Hollande, Sabrina Sidali, Bernardo Stefanini, Claudia Campani, Elisa Pellegrini, Giuseppe Cabibbo, Fabio Marra, Fabio Piscaglia, Antonio Gasbarrini, Maurizio Pompili, Mohamed Bouattour, Francesca Romana Ponziani
Publicado 2025Artigo -
3
Pathological response following neoadjuvant immune checkpoint inhibitors in patients with hepatocellular carcinoma: a cross-trial, patient-level analysis por Antonio D’Alessio, Bernardo Stefanini, Julia Blanter, Benjamin Adegbite, Fionnuala Crowley, Vincent Yip, Sarah Slater, Claudia Angela Maria Fulgenzi, Ciro Celsa, Giulia Francesca Manfredi, Madhava Pai, Robert Goldin, Stephen C. Ward, Maria Isabel Fiel, Daniel Shu, Yung‐Yeh Su, Alessio Cortellini, Marina Baretti, Robert Anders, Mark Yarchoan, Chiun Hsu, Thomas U. Marron, David J. Pinato
Publicado 2024Artigo -
4
Clinical impact of CEUS on non-characterizable observations and observations with intermediate probability of malignancy on CT/MRI in patients at risk for HCC por Yuko Kono, Fabio Piscaglia, Stephanie R. Wilson, Alexandra Medellin, Shuchi K. Rodgers, Virginia B. Planz, Aya Kamaya, David T. Fetzer, Annalisa Berzigotti, Paul S. Sidhu, Corinne E. Wessner, K. Bradigan, Cristina M. Kuon Yeng Escalante, Ting Xiao, John R. Eisenbrey, Flemming Forsberg, Andrej Lyshchik, Gibran Yusuf, Abid Suddle, Vasileios Rafailidis, Lorenzo Mulazzani, Alessandro Granito, Eleonora Terzi, A. Forgione, Alice Giamperoli, Bernardo Stefanini, Iuliana-Pompilia Radu, Lisa Finch, Amit G. Singal
Publicado 2024Artigo -
5
Sequential therapies after atezolizumab plus bevacizumab or lenvatinib first-line treatments in hepatocellular carcinoma patients por Mara Persano, Margherita Rimini, Toshifumi Tada, Goki Suda, Shigeo Shimose, Masatoshi Kudo, Jaekyung Cheon, Fabian Finkelmeier, Ho Yeong Lim, José Presa, Gianluca Masi, Changhoon Yoo, Sara Lonardi, Francesco Tovoli, Takashi Kumada, Naoya Sakamoto, Hideki Iwamoto, Tomoko Aoki, Hong Jae Chon, Vera Himmelsbach, Takashi Niizeki, Margarida Montes, Caterina Vivaldi, Caterina Soldà, Bernardo Stefanini, Atsushi Hiraoka, Takuya Sho, Naoshi Nishida, Christoph Steup, Massimo Iavarone, Giovanni Di Costanzo, Fabio Marra, Emiliano Tamburini, Giuseppe Cabibbo, Francesco Giuseppe Foschi, Marianna Silletta, Masashi Hirooka, Kazuya Kariyama, Joji Tani, Masanori Atsukawa, Koichi Takaguchi, Ei Itobayashi, Shinya Fukunishi, Kunihiko Tsuji, Toru Ishikawa, Kazuto Tajiri, Hironori Ochi, Satoshi Yasuda, Hidenori Toyoda, Chikara Ogawa, Takashi Nishimura, Takeshi Hatanaka, Satoru Kakizaki, Noritomo Shimada, Kazuhito Kawata, Fujimasa Tada, Hideko Ohama, Kazuhiro Nouso, Asahiro Morishita, Akemi Tsutsui, Takuya Nagano, Norio Itokawa, Tomomi Okubo, Taeang Arai, Michitaka Imai, Hisashi Kosaka, Atsushi Naganuma, Yohei Koizumi, Shinichiro Nakamura, Masaki Kaibori, Hiroko Iijima, Yoichi Hiasa, Claudia Campani, Elisabeth Amadeo, Federico Rossari, Valentina Burgio, Stefano Cascinu, Mario Scartozzi, Andrea Casadei‐Gardini
Publicado 2023Artigo -
6
Characteristics and outcomes of immunotherapy-related liver injury in patients with hepatocellular carcinoma versus other advanced solid tumours por Ciro Celsa, Giuseppe Cabibbo, Claudia Angela Maria Fulgenzi, Bernhard Scheiner, Antonio D’Alessio, Giulia Francesca Manfredi, Naoshi Nishida, Celina Ang, Thomas U. Marron, Anwaar Saeed, Brooke Wietharn, Matthias Pinter, Jaekyung Cheon, Yi‐Hsiang Huang, Pei‐Chang Lee, Samuel Phen, Anuhya Gampa, Anjana Pillai, Caterina Vivaldi, Francesca Salani, Gianluca Masi, Natascha Roehlen, Robert Thimme, Arndt Vogel, Martin Schönlein, Johann von Felden, Kornelius Schulze, Henning Wege, Peter R. Galle, Masatoshi Kudo, Lorenza Rimassa, Amit G. Singal, Paul El Tomb, Susanna V. Ulahannan, Alessandro Parisi, Hong Jae Chon, Wei‐Fan Hsu, Bernardo Stefanini, Elena Verzoni, Raffaele Giusti, Antonello Veccia, Annamaria Catino, Giuseppe Aprile, Pamela Francesca Guglielmini, Marilena Di Napoli, Paola Ermacora, Lorenzo Antonuzzo, Ernesto Rossi, Francesco Verderame, Fable Zustovich, Corrado Ficorella, Francesca Romana Di Pietro, Nicola Battelli, Giorgia Negrini, Francesco Grossi, Roberto Bordonaro, Stefania Pipitone, Maria Banzi, Serena Ricciardi, Letizia Laera, Antonio Russo, Ugo De Giorgi, Luigi Cavanna, Mariella Sorarù, Vincenzo Montesarchio, Paola Bordi, Leonardo Brunetti, Carmine Pinto, Melissa Bersanelli, Calogero Cammà, Alessio Cortellini, David J. Pinato
Publicado 2023Artigo -
7
Disease Etiology Impact on Outcomes of Hepatocellular Carcinoma Patients Treated with Atezolizumab plus Bevacizumab: A Real-World, Multicenter Study por Federico Rossari, Toshifumi Tada, Goki Suda, Shigeo Shimose, Masatoshi Kudo, Changhoon Yoo, Jaekyung Cheon, Fabian Finkelmeier, Ho Yeong Lim, José Presa, Gianluca Masi, Francesca Bergamo, Elisabeth Amadeo, Francesco Vitiello, Takashi Kumada, Naoya Sakamoto, Hideki Iwamoto, Tomoko Aoki, Hong Jae Chon, Vera Himmelsbach, Massimo Iavarone, Giuseppe Cabibbo, Margarida Montes, Francesco Giuseppe Foschi, Caterina Vivaldi, Caterina Soldà, Takuya Sho, Takashi Niizeki, Naoshi Nishida, Christoph Steup, Masashi Hirooka, Kazuya Kariyama, Joji Tani, Masanori Atsukawa, Koichi Takaguchi, Ei Itobayashi, Shinya Fukunishi, Kunihiko Tsuji, Toru Ishikawa, Kazuto Tajiri, Hironori Ochi, Satoshi Yasuda, Hidenori Toyoda, Chikara Ogawa, Takashi Nishimura, Takeshi Hatanaka, Satoru Kakizaki, Noritomo Shimada, Kazuhito Kawata, Atsushi Hiraoka, Fujimasa Tada, Hideko Ohama, Kazuhiro Nouso, Asahiro Morishita, Akemi Tsutsui, Takuya Nagano, Norio Itokawa, Tomomi Okubo, Michitaka Imai, Hisashi Kosaka, Atsushi Naganuma, Yohei Koizumi, Shinichiro Nakamura, Masaki Kaibori, Hiroko Iijima, Yoichi Hiasa, Mara Persano, Silvia Foti, Silvia Camera, Bernardo Stefanini, Mario Scartozzi, Stefano Cascinu, Andrea Casadei‐Gardini, Margherita Rimini
Publicado 2024Artigo
Herramientas de búsqueda:
Materias Relacionadas
Internal medicine
Medicine
Hepatocellular carcinoma
Chemotherapy
Gastroenterology
Immunotherapy
Oncology
Atezolizumab
Bevacizumab
Cancer
Nivolumab
Disease
Immunology
Antibody
Cancer research
Carcinoma
Chronic liver disease
Cirrhosis
Cohort
Complete response
Confidence interval
Cumulative incidence
Decompensation
Etiology
Fatty liver
Hazard ratio
Hepatology
Immune checkpoint
Immune system
Incidence (geometry)